These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 30044356)
1. Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis: GASTROENTEROLOGY: INFLAMMATORY BOWEL DISEASE. Gasparetto M; Wong-Spracklen V; Torrente F; Howell K; Brennan M; Noble-Jamieson G; Heuschkel R; Zilbauer M J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):217-220. PubMed ID: 30044356 [TBL] [Abstract][Full Text] [Related]
2. Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study. Iwańczak BM; Kierkuś J; Ryżko J; Szczepanik M; Więcek S; Czaja-Bulsa G; Kacperska M; Korczowski B; Maślana J; Iwańczak F Adv Clin Exp Med; 2017; 26(1):57-61. PubMed ID: 28397433 [TBL] [Abstract][Full Text] [Related]
3. Histological healing after infliximab induction therapy in children with ulcerative colitis. Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025 [TBL] [Abstract][Full Text] [Related]
4. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy. Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340 [TBL] [Abstract][Full Text] [Related]
5. Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm. Johnsen KM; Goll R; Hansen V; Olsen T; Rismo R; Heitmann R; Gundersen MD; Kvamme JM; Paulssen EJ; Kileng H; Johnsen K; Florholmen J Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):98-104. PubMed ID: 27749779 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients. Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E; Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840 [TBL] [Abstract][Full Text] [Related]
7. The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease. Hoekman DR; Brandse JF; de Meij TG; Hummel TZ; Löwenberg M; Benninga MA; D'Haens GR; Kindermann A Scand J Gastroenterol; 2015; 50(9):1110-7. PubMed ID: 25865965 [TBL] [Abstract][Full Text] [Related]
8. Assessment of induction therapy with infliximab in children with moderate to severe ulcerative colitis: a multi-center study. Szychta M; Wiernicka A; Dądalski M; Landowski P; Klincewicz B; Karolewska-Bochenek K; Czaja-Bulsa G; Jarocka-Cyrta E; Korczowski B; Sladek M; Kierkus J Dev Period Med; 2016; 20(3):205-211. PubMed ID: 27941190 [TBL] [Abstract][Full Text] [Related]
9. Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab. Saigusa K; Matsuoka K; Sugimoto S; Arai M; Kiyohara H; Takeshita K; Mizuno S; Mori K; Nanki K; Takeshita T; Nakazato Y; Yajima T; Naganuma M; Hisamatsu T; Ogata H; Iwao Y; Kanai T Dig Endosc; 2016 Sep; 28(6):665-70. PubMed ID: 26997640 [TBL] [Abstract][Full Text] [Related]
10. Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis. Murthy SK; Greenberg GR; Croitoru K; Nguyen GC; Silverberg MS; Steinhart AH Inflamm Bowel Dis; 2015 Sep; 21(9):2090-6. PubMed ID: 26099066 [TBL] [Abstract][Full Text] [Related]
11. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study. Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374 [TBL] [Abstract][Full Text] [Related]
12. Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study. Dhaliwal J; Tertigas D; Carman N; Lawrence S; Debruyn JC; Wine E; Church PC; Huynh HQ; Rashid M; El-Matary W; Deslandres C; Critch J; Ricciuto A; Carroll MW; Benchimol EI; Muise A; Jacobson K; Otley AR; Vallance B; Mack DR; Walters TD; Surette MG; Griffiths AM J Crohns Colitis; 2024 Feb; 18(2):233-245. PubMed ID: 37602969 [TBL] [Abstract][Full Text] [Related]
13. Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis. Taxonera C; Barreiro-de Acosta M; Calvo M; Saro C; Bastida G; Martín-Arranz MD; Gisbert JP; García-Sánchez V; Marín-Jiménez I; Bermejo F; Chaparro M; Ponferrada Á; Martínez-Montiel MP; Pajares R; de Gracia C; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I Dig Dis Sci; 2015 Oct; 60(10):3075-84. PubMed ID: 26044830 [TBL] [Abstract][Full Text] [Related]